Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Sonos lays off 200 employees amid ongoing troubles
Audio manufacturer Sonos laid off 200 employees Wednesday. The layoffs come weeks after its CEO was removed and a controller ...